AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
The current AstraZeneca(AZN) stock price is $190.17, with a market capitalization of 294.87B. The stock trades at a price-to-earnings (P/E) ratio of 29.12 and offers a dividend yield of 1.61%.
As of 2026-07-06, AstraZeneca(AZN) stock has fluctuated between $186.24 and $190.57. The current price stands at $190.17, placing the stock +2.1% above today's low and -0.2% off the high.
The AstraZeneca(AZN)'s current trading volume is 1.65M, compared to an average daily volume of 2.1M.
During the past year, AstraZeneca(AZN) stock moved between $137.23 at its lowest and $212.71 at its peak.
During the past year, AstraZeneca(AZN) stock moved between $137.23 at its lowest and $212.71 at its peak.
AZN News
...
AstraZeneca, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank of America Securities reiterated a Buy r...
The partnership follows regulatory clearance in China for a Phase 1/2 study evaluating Abbisko’s oral PD-L1 inhibitor, lumipodlin (ABSK043), alongside AstraZene...
Analyst ratings
83%
of 30 ratingsMore AZN News
AstraZeneca (AZN) has reached a partnership worth up to $1.77B with CSPC Pharmaceutical Group (CSPCY) to develop and commercialize treatments for kidney diseas...
Abbisko Therapeutics announced that it has entered into a strategic collaboration agreement with AstraZeneca (AZN) to jointly advance the clinical development o...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium fo...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
AstraZeneca AZN and its Japan-based partner Daiichi Sankyo announced that the European Commission (EC) has approved their blockbuster antibody-drug conjugate (A...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.